Segmented nucleic acids
The non-nucleotide linker formed through chemical ligation solves the problems of long nucleic acid synthesis and purification, realizes efficient synthesis and the preparation of functional segmented nucleic acids, simplifies the isolation and purification process, and provides effective gene editing and disease treatment. therapeutic agent.
CN118922536APending Publication Date: 2024-11-08钟明宏
7 Cites 0 Cited by
Patent Information
- Application Number
- CN202280090463.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2022-06-14
- Filing Date
- 2022-11-30
- Publication Date
- 2024-11-08
Smart Images

Figure CN118922536A_ABST
Abstract
The present invention provides processes and methods for preparing segmented nucleic acids comprising at least two non-nucleotide linkers and conjugates of segmented nucleic acids and RNP complexes thereof with RNA-guided gene editing proteins, including CRISPR Cas proteins and ADAR enzymes. Also disclosed is the use of compositions comprising segmented nucleic acids or conjugates of segmented nucleic acids as medicaments for the treatment of disease.
Need to check novelty before this filing date? Find Prior Art
Citation Information
Patent Citations
Chemically ligated RNAs for CRISPR / Cas9-lgRNA complexes as antiviral therapeutic agents
US10059940B2
Crispr oligonucleotides and gene editing
US20160102322A1
Guide RNA with chemical modifications
US20160289675A1
Segmented Nucleic Acids
US20230167441A1
Use of unstructured nucleic acids in assaying nucleic acid molecules
US7371580B2
